I have a Bachelor’s Degree in Biochemistry from the Faculty of Science and Technology of the University of Coimbra (2018-2021). During my Bachelor’s, in my Undergraduate Project, I studied the radiobiological effects of Radium-223 in 3D spheroids of prostate carcinoma, which allied to the Specialization Course in “Cell Culture and Tissue Training” that I did, allowed me to learn the basilar skills of cell culture. Besides this, I have a Master’s Degree in Clinical Laboratory Genetics from the Faculty of Medicine of the University of Coimbra (2021-2023). In my thesis, entitled “Genetic Analysis of Patients with Frontotemporal Dementia and Generation of induced Pluripotent Stem Cells and Brain Organoids”, I had two main goals. Firstly, I employed Sanger Sequencing and NGS to diagnose Frontotemporal Dementia patients with mutations in GRN and C9ORF72 genes, under the supervision of Maria do Rosário Almeida in the Neurogenetics Laboratory of CNC. Secondly, I established human induced pluripotent stem cells (iPSCs) from patient-derived fibroblasts and derived human 3D brain organoids from these lines, in the Neuronal Circuits and Behavior Laboratory of CNC under the supervision of Ana Luísa Cardoso and João Peça. This gave me valuable insights and knowledge in advanced cell culture techniques, cell and tissue immunostaining, confocal microscopy, real-time PCR and cryosectioning. My work allowed me to present a poster entitled “Generation and Characterization of induced pluripotent stem cells derived from human dermal fibroblast lines” at FENS Regional Meeting. I also attended the VII Symposium Portuguese Glial Network, where I was co-author of a poster. Until June, I was awarded a 6-month fellowship, in the Advanced Therapies Group, under the supervision of Susana Rosa and Lino Ferreira. Here, I had the opportunity not only to delve deeper into immunofluorescence techniques and data analysis but also to expand my skill set to include Flow Cytometry and the differentiation of human iPSCs (derived from patients with POMPE disease) into skeletal muscle cells, to generate disease models and for drug screening tests to uncover novel therapeutic targets for rare muscular disorders.